| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/22/2007 | CN101022822A Liquid preparation of physiologically active peptide |
| 08/22/2007 | CN101022821A Use of aspartate for regulating glucose levels in blood |
| 08/22/2007 | CN101022820A Method and device for diagnosing and treating insulin-like growth factor deficiency disorders |
| 08/22/2007 | CN101022737A Anti-hypertensive functional food products |
| 08/22/2007 | CN101020715A Process of extracting and preparing deer nerve growth factor (DEER NGF) |
| 08/22/2007 | CN101020714A Earthworm protein with function of lowering blood pressure and its prepn process |
| 08/22/2007 | CN101020711A New gene MgCON3 generated in controlling conidium with pathogenic fungus and its use |
| 08/22/2007 | CN101020710A Integrase inhibiting peptide and its application in preparing AIDS-treating medicine |
| 08/22/2007 | CN101020049A Use of ulinastatin in preparing medicine for treating and/or preventing spinal cord injury |
| 08/22/2007 | CN101020048A Pyemia treating medicine composition |
| 08/22/2007 | CN101020047A Health food containing calcium reinforcing agent |
| 08/22/2007 | CN101020046A Fast hymen Yegenerating repair medicine |
| 08/22/2007 | CN101020045A New use of agglutinin |
| 08/22/2007 | CN101020044A Regulating and controlling effect of thymine DNA glycosylase on signal transducing path |
| 08/22/2007 | CN101019889A Prepn process of brain protein hydrolysate injection |
| 08/22/2007 | CN101019836A Nanometer cytochrome liposome medicine and its prepn |
| 08/22/2007 | CN101019828A Anticancer composition containing both phosphoinositide-3-kinase inhibitor and hormone medicine |
| 08/21/2007 | USRE39789 Tumor therapy |
| 08/21/2007 | USRE39788 Introducing autologous human cells into a human, autologous human cells having been treated in vitro to insert therein a DNA segment encoding a therapeutic protein, autologous human cells expressing in vivo in human a therapeutically effective amount of therapeutic protein |
| 08/21/2007 | US7259258 Methods of attaching biological compounds to solid supports using triazine |
| 08/21/2007 | US7259254 Isolated, hybrid nucleic acids capable of binding to ligand; transcription activation |
| 08/21/2007 | US7259247 Against the costimulatory surface molecule, natural or synthetic ligands, agonists or antagonists of the surface molecule. |
| 08/21/2007 | US7259246 Hybridoma cell line producing monoclonal antibodies to bind to, to detect and qualitatively and quantitatively measure the presence of epitopes of prion proteins; neurodegenerative diseases of the central nervous system |
| 08/21/2007 | US7259244 Human homologue of the DBF4/ASK1 protein, nucleic acids, and methods related to the same |
| 08/21/2007 | US7259243 Process for isolation of osteopontin from milk |
| 08/21/2007 | US7259237 Reducing the disulfide bond in a precursor molecule of viral neuraminidase inhibitors, subsequently alkylating the reduced disulfide bonds with an alkylating agent. |
| 08/21/2007 | US7259236 RBP1L1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof |
| 08/21/2007 | US7259234 Stable analogs of peptide and polypeptide therapeutics |
| 08/21/2007 | US7259233 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 08/21/2007 | US7259232 Preferred segments of neural thread protein |
| 08/21/2007 | US7259181 β crystalline form of perindopril tert-butylamine salt |
| 08/21/2007 | US7259150 Oligonucleotides; nucleic acid; therapy, diagnosis; cardiovascular disorders, atherosclerosis, anticholesterol agents |
| 08/21/2007 | US7259147 treating multiple sclerosisbby administering an inhibitor of JTT-1 antigen activity. |
| 08/21/2007 | US7259146 Stimulate hematopoiesis; administering peptide |
| 08/21/2007 | US7259145 Mechanically activated channel blocker |
| 08/21/2007 | US7259144 Methods for diagnosing and treatment of hyperphosphatemic conditions using FGF20 polypeptides |
| 08/21/2007 | US7259143 Administering an appropriate dosage schedule of a bone calcium resorption inhibitor and a toxic dose of a vitamin d without developing hypercalcemia |
| 08/21/2007 | US7259142 Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use |
| 08/21/2007 | US7259141 prepared via chemoenzymatic techniques; contain a 1,2,3-triazole moeity attached to the sugar group; glycosylating a vancomycin aglycone with a sugar transferase, then reacting with an alkyne via a 1,3-dipolar cycloaddition; treating vancomycin resistant infections |
| 08/21/2007 | US7259140 May be conjugated to a carrier molecule such as collagen, hyaluronic acid or agarose and additionally conjugated to a surgical sheet or mat |
| 08/21/2007 | US7259139 Insulin, and a polymeric matrix with a core of biodegradable, hydrophobic alpha -cyanacrylate polymer, and an outer shell of a biodegradable, hydrophobic copolymer of N-vinylpyrrolidone and an acrylic monomer; may also contain a histone; not more than 50-wt. % of the matrix degrades during one month. |
| 08/21/2007 | US7259138 Anti-tumor agents |
| 08/21/2007 | US7259137 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases |
| 08/21/2007 | US7259136 Administering glucagen-like peptide |
| 08/21/2007 | US7259022 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 08/21/2007 | US7258999 parathyroid hormone (PTH) for drug screening, diagnosis and development of therapies for bone related disorders; genetic engineering |
| 08/21/2007 | US7258996 Contacting lactic acid bacteria with milk to form a mixture, wherein bacteria comprises Lactobacillus helveticus, fermenting mixture under conditions to partially hydrolyze the casein of milk into casein-derived peptides to provide a fermented dairy product containing metalloproteinases inhibitory agent |
| 08/21/2007 | US7258995 Modulation gene expression |
| 08/21/2007 | US7258992 Reacting biological sample with a multiple epitope fusion polypeptide, detecting the presence or absence of complex, and thereby detecting the presence or absence of Streptococcus antibodies in sample |
| 08/21/2007 | US7258991 Antibody to bladder cancer nuclear matrix protein and its use |
| 08/21/2007 | US7258983 Cardiotrophin-1 compositions and methods for the treatment of tumor |
| 08/21/2007 | US7258973 Oligonucleotide sequences for use in the diagnosis and treatment of colon cancer |
| 08/21/2007 | US7258876 applying a mixture of melaleuca alternifolia extract oil, an immunostimulant and an antioxidant; treats most every type of infection caused by pathogenic organisms with little or no side effects. |
| 08/21/2007 | US7258864 Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency |
| 08/21/2007 | US7258861 Peptides derived from the region of human TNF- alpha from Ser100 to Glu116 to treat pulmonary oedema. |
| 08/21/2007 | US7258860 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/21/2007 | US7258859 Method for the treatment of multiple sclerosis |
| 08/21/2007 | US7258857 Rage-related methods for treating inflammation |
| 08/21/2007 | US7258856 Isolated from the genus Carica; proteases are cysteine proteases isolated from Carica candamarcensis; recombinant forms of the protease, including fragments and mutants; use as a wound healing promoter |
| 08/21/2007 | US7258855 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
| 08/21/2007 | US7258854 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 08/21/2007 | US7258853 Mutant cytokine polypeptide; immunosuppressant; immunotherapy; antitumor agents |
| 08/21/2007 | US7258850 Methods and compositions for treating erectile dysfunction |
| 08/21/2007 | CA2288958C Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation |
| 08/21/2007 | CA2285054C Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof |
| 08/21/2007 | CA2247966C Murine .alpha.(1,3)fucosyltransferase fuc-tvii, dna encoding the same and uses thereof |
| 08/21/2007 | CA2222425C Immortalization and disimmortalization of cells |
| 08/21/2007 | CA2196419C Improvements in or relating to binding proteins for recognition of dna |
| 08/21/2007 | CA2165995C Medicaments for the treatment of restenosis and arterial sclerosis |
| 08/21/2007 | CA2150940C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 08/21/2007 | CA2139468C Methods for preventing degradation of protein c |
| 08/21/2007 | CA2071950C Collagen binding protein as well as its preparation |
| 08/21/2007 | CA2070004C Cloned glutamic acid decarboxylase |
| 08/16/2007 | WO2007092829A2 Stabilized compositions of proteins having a free thiol moiety |
| 08/16/2007 | WO2007092645A2 Novel hcv inhibitor combinations and methods |
| 08/16/2007 | WO2007092616A2 Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto |
| 08/16/2007 | WO2007092537A2 Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same |
| 08/16/2007 | WO2007092447A2 Methods and compositions related to targeting tumors and wounds |
| 08/16/2007 | WO2007092161A2 A direct cellular energy delivery system |
| 08/16/2007 | WO2007091959A1 Novel antimicrobial peptides and use thereof |
| 08/16/2007 | WO2007091958A1 Novel antimicrobial peptides and use thereof |
| 08/16/2007 | WO2007091681A1 Radiotherapy enhancing agent in radiotherapy for tumor |
| 08/16/2007 | WO2007091678A1 Rheumatoid arthritis-preventive agent for oral intake |
| 08/16/2007 | WO2007091395A1 Method or agent for inhibiting the function of efflux pump of pseudomonas aeruginosa |
| 08/16/2007 | WO2007091387A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 08/16/2007 | WO2007091240A2 Treatment of immunological diseases |
| 08/16/2007 | WO2007091078A2 Polypeptide conjugate comprising hla-g and uses thereof, stem cells transfected with hla-g |
| 08/16/2007 | WO2007091017A1 Amino acid derivatives |
| 08/16/2007 | WO2007090913A1 Use of pi3k activity agonist compounds in the production of pharmaceutical compositions, the resulting pharmaceutical compositions and applications thereof in the treatment of diseases |
| 08/16/2007 | WO2007090912A1 IN VITRO USE OF NF-kB INHIBITORS TO INDUCE THE SELECTIVE DEPLETION OF ALLOREACTIVE T-LYMPHOCYTES, DERIVATIVE PHARMACEUTICAL COMPOSITIONS AND USES OF SAME |
| 08/16/2007 | WO2007090911A1 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 08/16/2007 | WO2007090870A1 Process for preparing a particle comprising a biological molecule and a carrier polymer |
| 08/16/2007 | WO2007090862A2 Neutral sphingomyelinase-3 and its use |
| 08/16/2007 | WO2007090630A2 Peptide aptamer for neutralizing the binding of platelet antigene specific antibodies and diagnostic and therapeutic applications containing the same |
| 08/16/2007 | WO2007090584A1 Modified coagulation factor vila with extended half-life |
| 08/16/2007 | WO2007090504A1 Hydrolysed collagen and uses therof |
| 08/16/2007 | WO2007090290A1 Synthesis of sialic acid in plants |
| 08/16/2007 | WO2007076354A3 Stable protein formulations |
| 08/16/2007 | WO2007071874A3 Novel compounds which interact with pea-15 |
| 08/16/2007 | WO2007067964A3 Mucosal delivery of stabilized formulations of exendin |